Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petro E Petrides

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Diagnostics (Basel, Switzerland)|July 27, 2022
Therapy Follows Diagnosis: Old and New Approaches for the Treatment of Acute Porphyrias, What We Know and What We Should KnowPetro E Petrides
Expert Opinion on Pharmacotherapy|July 22, 2004
Anagrelide: a decade of clinical experience with its use for the treatment of primary thrombocythaemiaPetro E Petrides
Medizinische Klinik (Munich, Germany : 1983)|August 10, 2006
[Primary thrombocythemia: diagnosis and therapy]Petro E Petrides
Seminars in Thrombosis and Hemostasis|July 1, 2006
Anagrelide: what was new in 2004 and 2005?Petro E Petrides
Cureus|April 3, 2026
Real-World Experience With Givosiran in Acute Porphyrias: A Narrative Review and a Novel HypothesisPetro E Petrides
Blood Cells, Molecules & Diseases|March 28, 2006
Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddlesPetro E Petrides, Fabian Siegel
Deutsche Medizinische Wochenschrift (1946)|November 26, 2021
Petro E Petrides, Maria K Beykirch
Deutsches Arzteblatt International|July 28, 2009
Congenital and acquired polycythemiasFabian P Siegel, Petro E Petrides
Haematologica|March 12, 2010
Hydroxyurea induced oscillations in twelve patients with polycythemia veraJan Tauscher, Fabian Siegel, Petro E Petrides
Blood Cells, Molecules & Diseases|October 24, 2007
The high oxygen-affinity Hemoglobin Johnstown [(beta 109(G11) Val-->Leu] in a German kindred with an elevated erythrocyte hemoglobin content: potential interaction with HFE mutationsPetro E Petrides, Maria K Beykirch, Elisabeth Kohne
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Diagnostics (Basel, Switzerland)|July 27, 2022
Therapy Follows Diagnosis: Old and New Approaches for the Treatment of Acute Porphyrias, What We Know and What We Should KnowPetro E Petrides
Expert Opinion on Pharmacotherapy|July 22, 2004
Anagrelide: a decade of clinical experience with its use for the treatment of primary thrombocythaemiaPetro E Petrides
Medizinische Klinik (Munich, Germany : 1983)|August 10, 2006
[Primary thrombocythemia: diagnosis and therapy]Petro E Petrides
Seminars in Thrombosis and Hemostasis|July 1, 2006
Anagrelide: what was new in 2004 and 2005?Petro E Petrides
Cureus|April 3, 2026
Real-World Experience With Givosiran in Acute Porphyrias: A Narrative Review and a Novel HypothesisPetro E Petrides
Blood Cells, Molecules & Diseases|March 28, 2006
Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddlesPetro E Petrides, Fabian Siegel
Deutsche Medizinische Wochenschrift (1946)|November 26, 2021
Petro E Petrides, Maria K Beykirch
Deutsches Arzteblatt International|July 28, 2009
Congenital and acquired polycythemiasFabian P Siegel, Petro E Petrides
Haematologica|March 12, 2010
Hydroxyurea induced oscillations in twelve patients with polycythemia veraJan Tauscher, Fabian Siegel, Petro E Petrides
Blood Cells, Molecules & Diseases|October 24, 2007
The high oxygen-affinity Hemoglobin Johnstown [(beta 109(G11) Val-->Leu] in a German kindred with an elevated erythrocyte hemoglobin content: potential interaction with HFE mutationsPetro E Petrides, Maria K Beykirch, Elisabeth Kohne
Pageof 4